{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:26:50Z","timestamp":1790126810450,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/jpet.118.254672","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T02:25:16Z","timestamp":1545963916000},"page":"843-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations"],"prefix":"10.1016","volume":"370","author":[{"given":"Sunita","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grishma","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-881X","authenticated-orcid":false,"given":"Mansoor","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.254672_bib1","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1248\/cpb.43.2232","article-title":"Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin","volume":"43","author":"Abe","year":"1995","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/jpet.118.254672_bib2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jps.21031","article-title":"Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies","volume":"97","author":"Bai","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.254672_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.58.1.0008","article-title":"Carbamazepine uptake into rat brain following intra-olfactory transport","volume":"58","author":"Barakat","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.118.254672_bib4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/jpet.118.254672_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jps.1122","article-title":"Direct nose-brain transport of benzoylecgonine following intranasal administration in rats","volume":"90","author":"Chow","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.118.254672_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther Deliv"},{"key":"10.1124\/jpet.118.254672_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pbb.2004.02.018","article-title":"Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects","volume":"78","author":"Foltin","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.118.254672_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cellbi.2009.04.006","article-title":"Effect of FK506 and cyclosporine A on the expression of BDNF, Tyrosine kinase B and p75 neurotrophin receptors in astrocytes exposed to simulated ischemia in vitro","volume":"33","author":"Gabryel","year":"2009","journal-title":"Cell Biol Int"},{"key":"10.1124\/jpet.118.254672_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1096-9861(19960819)372:2<283::AID-CNE9>3.0.CO;2-#","article-title":"Neuronal localization of the Cyclophilin A protein in the adult rat brain","volume":"372","author":"G\u00f6ldner","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.118.254672_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.118.254672_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1215\/15228517-2007-052","article-title":"New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163","volume":"10","author":"Hashizume","year":"2008","journal-title":"Neuro-oncol"},{"key":"10.1124\/jpet.118.254672_bib12","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/bm2017993","article-title":"Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system","volume":"13","author":"Jain","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1124\/jpet.118.254672_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WAD.0b013e318157205b","article-title":"Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting","volume":"22","author":"Jogani","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1124\/jpet.118.254672_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1124\/jpet.118.254672_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/714044702","article-title":"Morphogenesis of postmortem hepatocyte vacuolation and liver weight increases in Sprague-Dawley rats","volume":"31","author":"Li","year":"2003","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.118.254672_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-3565(24)38877-9","article-title":"Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide","volume":"295","author":"Liu","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.254672_bib17","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.118.254672_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cbpa.2018.04.006","article-title":"Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo","volume":"45","author":"Lux","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/jpet.118.254672_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/jpet.118.254672_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv"},{"key":"10.1124\/jpet.118.254672_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0306-4522(01)00225-1","article-title":"Involvement of the brain-derived neurotrophic factor\/TrkB pathway in neuroprotecive effect of cyclosporin A in forebrain ischemia","volume":"105","author":"Miyata","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.118.254672_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1097-0142(196402)17:2<170::AID-CNCR2820170206>3.0.CO;2-N","article-title":"Studies of a human tumor cell line with a diploid karyotype","volume":"17","author":"Moore","year":"1964","journal-title":"Cancer"},{"key":"10.1124\/jpet.118.254672_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.npep.2011.04.002","article-title":"Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application","volume":"45","author":"Osman","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.118.254672_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1166\/jbn.2006.038","article-title":"Preparation and in vitro characterization of multifunctional nanoemulsions for simultaneous MR imaging and targeted drug dleivery","volume":"2","author":"Sandip","year":"2006","journal-title":"J Biomed Nanotechnol"},{"key":"10.1124\/jpet.118.254672_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1528-1157.2003.66302.x","article-title":"Protection provided by cyclosporin A against excitotoxic neuronal death is genotype dependent","volume":"44","author":"Santos","year":"2003","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.118.254672_bib26","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/foc.2006.20.5.10","article-title":"Potentiation of neurite outgrowth and reduction of apoptosis by immunosuppressive agents: implications for neuronal injury and transplantation","volume":"20","author":"Sheehan","year":"2006","journal-title":"Neurosurg Focus"},{"key":"10.1124\/jpet.118.254672_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J Control Release"},{"key":"10.1124\/jpet.118.254672_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-6147(97)01146-2","article-title":"Neural actions of immunophilin ligands","volume":"19","author":"Snyder","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.118.254672_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","article-title":"Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system","volume":"16","author":"Tom\u00e1s-Camardiel","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.118.254672_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2009.08.008","article-title":"RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies","volume":"74","author":"Wengst","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.118.254672_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejps.2005.01.009","article-title":"Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents","volume":"24","author":"Westin","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.118.254672_bib32","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation","volume":"12","author":"Yadav","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.118.254672_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2014.06.017","article-title":"Agile delivery of protein therapeutics to CNS","volume":"190","author":"Yi","year":"2014","journal-title":"J Control Release"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.254672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:54:07Z","timestamp":1739994847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0022356524260560"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.254672","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.254672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}